Faculty Disclosures
In accordance with Joint Accreditation criteria and the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education, the Association of Diabetes Care & Education Specialists (ADCES) must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all relevant financial relationships with any ineligible companies for the past 24 months.
Joint Accreditation/ACCME requires ADCES to identify and mitigate all relevant financial relationships with ineligible companies to ensure educational content is balanced, evidence-based, and free from bias. Disclosure information is provided to help learners recognize any relevant financial relationships and make their own informed judgments about the content. If you perceive any bias during the activity, please report it through the evaluation form.
Relevant disclosures (or lack thereof) among educational activity planners and faculty are as follows:
Planners
Dana Moreau – No relevant financial relationships
LaurieAnn Scher, MS, RD, CDCES, FADCES – Consultant: GlucoSense, HousecallVR
Presenters
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP - Speaker/Consultant: Dexcom, Abbott, Sanofi, Insulet, Tandem, Ascensia, Medtronic, Novo Nordisk, Lilly, Beta Bionics
Peer Reviewers
Charles D. Ponte, BS Pharm, PharmD, BC-ADM, CDCES – No relevant financial relationships
Nancy Ryan, RD, MS, BC-ADM, CDCES – No relevant financial relationships
Lisa B. Smith, MSN, FNP-C, CDCES, BC-ADM – No relevant financial relationships
All relevant financial relationships have been mitigated.
The approval of this educational offering by the ADCES does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.
Financial Support
This activity is supported by The Leona M. and Harry B. Helmsley Charitable Trust.